Establishment of a murine epidermal cell line suitable for in vitro and in vivo skin modelling
© Segrelles et al; licensee BioMed Central Ltd. 2011
Received: 25 November 2010
Accepted: 21 April 2011
Published: 21 April 2011
Skin diseases are a major health problem. Some of the most severe conditions involve genetic disorders, including cancer. Several of these human diseases have been modelled in genetically modified mice, thus becoming a highly valuable preclinical tool for the treatment of these pathologies. However, development of three-dimensional models of skin using keratinocytes from normal and/or genetically modified mice has been hindered by the difficulty to subculture murine epidermal keratinocytes.
We have generated a murine epidermal cell line by serially passaging keratinocytes isolated from the back skin of adult mice. We have termed this cell line COCA. Cell culture is done in fully defined media and does not require feeder cells or any other coating methods.
COCA retained its capacity to differentiate and stratify in response to increased calcium concentration in the cell culture medium for more than 75 passages. These cells, including late passage, can form epidermis-like structures in three-dimensional in vitro models with a well-preserved pattern of proliferation and differentiation. Furthermore, these cells form epidermis in grafting assays in vivo, and do not develop tumorigenic ability.
We propose that COCA constitutes a good experimental system for in vitro and in vivo skin modelling. Also, cell lines from genetically modified mice of interest in skin biology could be established using the method we have developed. COCA keratinocytes would be a suitable control, within a similar background, when studying the biological implications of these alterations.
Skin diseases affect patients of all ages worldwide. By some estimates, they affect 50 percent or more of the population at any one time and comprise over 2,000 medical conditions which can range from only mild skin problems to pathologies that are serious or even fatal. The aetiology of skin diseases is varied and some of the most severe are autoimmune and genetic disorders, including cancer.
Skin tissue engineering techniques emerged in the 1980s to address the need for extensive full-thickness burns coverage in the absence of sufficient autologous skin for grafting [1–3]. In the clinical context they are also useful in treating non-healing ulcers [4, 5]. In addition to its clinical applications, three-dimensional models (3D) of engineered skin are being broadly used in skin biology research, such as reducing animal experimentation (i.e. animal testing for human skin products), investigation of cell interactions and skin barrier penetration, and the development of models of human skin diseases, such as psoriasis [6–8] and the genetic disorder epidermolysis bullosa [9, 10].
Over the last years, genetically modified (transgenic and/or null) mouse models have been developed that recapitulate to a variable extent human diseases, including skin disorders. There is a lot to learn from engineered epidermis using keratinocytes from these animal models. However, despite the early success in culturing human keratinocytes , primary murine keratinocytes have shown to be fairly reluctant to subculture and expansion in vitro, thus precluding the establishment of reproducible 3D models to be used in skin biology research. Initial attempts to culture murine keratinocytes long-term required the use of matrix coated dishes and/or complex fibroblast-conditioned media with fetal bovine serum for cell seeding and growth [12–14]. These cells retained their ability to differentiate, when the concentration of calcium in the culture media was increased, only until passage 10  to 15 . Caldelari et al.  and Reichelt & Haase  achieved serial subculture of murine epidermal keratinocytes for more than 50 and 250 passages, respectively. While Reichelt & Haase method still required the use of feeder cells in the initial phases of growth, collagen-coated dishes and serum-conditioned culture media, Caldelari et al.  subcultured cells in uncoated culture dishes and fully defined media. Also, they showed that their cell line retained the capacity to respond to the elevation of calcium concentration in the culture media with the establishment of intercellular adhesion complex and the expression of terminal differentiation markers.
There has been great advance in the development of fully defined media to culture keratinocytes and to establish 3D epidermal models; however, theses advances are being focused and tested on primary human epidermal keratinocytes. In fact, when compared to the field of human tissue-engineered skin (for a review ), current experience on 3D models using cultured murine keratinocytes is scarce, consisting of organotypic cultures that use devitalised dermis and complex non-defined culture media [13, 18].
We have established a murine keratinocyte cell line that grows on conventional cell culture plastic dishes and with defined culture media. These cells retain its potential to differentiate for more than 75 passages when the calcium concentration is increased, and form an epidermis-like structure using the abovementioned 3D protocols. This murine cell line, termed COCA, is non-tumorigenic and can also form an epidermis in vivo when grafted onto immunodeficient mice. We propose that our cell culture technique is suitable for the establishment of other murine cell lines bearing different genetic manipulations and that these cell lines can be used to establish reproducible 3D epidermal models appropriate for skin biology research.
Cell isolation and culture
Keratinocytes were isolated from the back skin of 2-months old C57BL/DBA mice using a protocol suitable for adult skin . They were maintained in culture in a low calcium (0.07 mM) progenitor cell targeted fully defined media, CnT-07 (CELLnTEC, Bern, Switzerland), in an incubator at 37°C and 5% CO2. At confluency, cells were subcultured by trypsinisation and plated at 4.5-5.5 × 103 cells per cm2 in seeding media (EMEM, 4% FBS pre-treated with Chelex 100 resin, 0.2 mM CaCl2) for 8-14 hours to allow cell adhesion. Then, culture plates were washed twice with PBS to eliminate calcium, and switched to CnT-07 to promote cell growth and prevent differentiation. FBS-seeding media is not further needed once the cell line has been established (>20 passages). At this point, 8-14 hours incubation in CnT-07 medium containing 0.2 mM CaCl2 is enough to ensure good cell attachment after trypsinisation.
Conventional in vitro keratinocyte differentiation was initiated when cells were confluent by changing the low calcium (0.07 mM) media to a high calcium (1.2 mM) differentiation media. This elevation in the concentration of calcium induces the cells to differentiate [20–22]. Bromodeoxyuridine 10 μM (BrdU) (Sigma Aldrich, St. Louis, MO) was added to the culture medium 1 hour before sample fixation.
Three-dimensional (3D) in vitro epidermal cell cultures were established by culturing COCA in CELLnTEC fully defined cell culture media following the manufacturer's recommendations, in the absence of fibroblasts or other supporting cells. Briefly, 200,000 cells were seeded into Millipore PCF 0.4 μm inserts placed in a Petri dish. Cells were grown for four days in CnT-07, and switched to CnT-02-3D when they reached confluency. Culture media in and outside the inserts was left for an overnight; then, culture media inside the inserts was aspirated to start the stratification process. This system creates an air/liquid interface that allows the formation of a multilayered structure with a population of proliferative cells in the basal layer and a differentiated progeny. CnT-02-3D media was changed every 2-3 days. Development of 3D epidermal cell cultures was followed for 3 weeks.
All the animal work was approved by the Animal Ethical Committee (CEEA) and conducted in compliance with Centro de Investigaciones Energéticas, Medioambietales y Tecnológicas (CIEMAT) guidelines. NMRI nude (nu/nu) immunodeficient 5-week old female mice were obtained from Janvier (Saint-Berthevin, France) and housed in our animal facilities for 1-2 weeks prior to any experimental procedures. Mice were injected intraperitoneally with 100 μg of BrdU (dissolved in 0.09% NaCl) per g of body weight 1 hour before they were sacrificed to analyse proliferation (BrdU incorporation).
To assay tumour-formation ability, 1 × 106 COCA cells in late passages (>70) were resuspended in 100 μl saline buffer and injected subcutaneously on the flanks of NMRI nude mice. Both flanks were used, in one COCA were injected alone, in the other they were combined with 0.5 × 106 dermal fibroblasts. The experiment was repeated three times using 5 mice (x2 flanks) per experiment. Tumour growth was not evident, and animals were sacrificed and studied at 4-6 months to search for any indication of tumour.
Cell grafting assay
To assay the ability of COCA cells to engraft we followed a protocol adapted from Strachan and Ghadially . Briefly, mice were anesthetised and an excision approximately 5 mm in length was performed in the dorsal skin just between the shoulder blades. Silicone chambers with a 7 mm internal diameter (Renner, Dannstadt, Germany) were implanted and sutured in place when required. COCA epidermal keratinocytes (1.5 × 106) in passage 77 were mixed with dermal fibroblasts (0.5 × 106), resuspended in a final volume of 100 μl PBS and injected into the silicon chambers. The cells were allowed 20 min to settle and adhere before waking up the mice. Epidermis formed by grafted COCA + fibroblasts was harvested 4 weeks after chamber implantation. Mice were injected i.p. with 100 μg/g of body weight BrdU 1 h before they were sacrificed to analyse proliferation.
For histological analysis, cells and tissue samples were fixed in 4% paraformaldehyde and embedded in paraffin prior to sectioning. Sections 3-4 μm thick were stained and processed as described . For BrdU detection, prior to blocking with serum, samples were incubated for 30 min in 1 N HCl (cells) or 1 h in 2 N HCl (tissue). Primary antibodies used were rabbit polyclonal anti-K5, anti-K6, Loricrin, Filaggrin (Covance, Emeryville, CA), and anti-BrdU (AbCam, Cambridge, UK); and mouse monoclonal anti-K10 (for cells clone RKSE60, St. Cruz Biotechnology, Santa Cruz, CA; for tissue sections DE-K10, DakoCytomation, Denmark A/S) and anti-PCNA (clone PC10 Thermo Scientific, Fremount, CA). FITC or TexasRed conjugated secondary antibodies were purchased from Jackson ImmunoResearch (West Grove, PA). Control slides were obtained by replacing primary antibodies with PBS or preimmune sera.
Establishment of a long-term culture of murine epidermal keratinocytes
Keratinocytes were isolated from the back skin of 2-months old C57BL/DBA mice and maintained in culture in low calcium (0.07 mM) fully defined media (CnT-07). Cells were repeatedly passaged to establish a cell line. We termed this murine epidermal keratinocyte derived cell line COCA, and we have expanded it in culture for more than 80 passages. COCA cell line has been deposited (October 2010) under the reference 10112001 with ECACC (European Collection of Cell Cultures, http://www.hpacultures.org.uk/products/celllines/generalcell/detail.jsp?refId=10112001&collection=ecacc_gc).
Cytogenetic study (SKY) of COCA epidermal keratinocytes at different passages.
der(4)T(2;4) + 2 centromeric fagments
Formation of conventional and 3D epidermal differentiation in vitro models
The epidermis is a multilayered epithelium where the process of terminal differentiation takes place as the committed cells in the basal proliferative compartment arrest proliferation and move upwards towards the epidermal surface. This process is accompanied by changes in the expression of keratins and other proteins. Keratin 5 (K5) is expressed in the basal layer, where proliferation occurs, and marks undifferentiated cells. Once the cells start the differentiation program they cease the expression of K5 and start the synthesis of the keratin K10, which is considered as an early marker of differentiation in vivo and in vitro. Terminal differentiation is indicated by the expression of loricrin and filaggrin. The keratin K6 is induced in the interfollicular epidermis as consequence of inflammatory and/or hyperproliferative stimuli, and in many circumstances this is in parallel with reduced K10 expression and expansion of K5 to suprabasal layers.
COCA keratinocytes are non-tumorigenic and regenerate epidermis in in vivo assays
To explore whether prolonged culture conditions might have conferred tumorigenic potential to COCA cells we performed in vivo tumorigenicity assays using immunodeficient mice [25–27]. In this assays, keratinocytes were injected in the flanks of nu/nu mice alone or mixed with dermal fibroblasts to help sustain keratinocyte growth. After 4-6 months there was no external sign of tumour growth and animals were sacrificed and studied to search for any evidence of tumour formation. Experiments using genetically modified murine keratinocytes were done in parallel and yielded 100% tumour growth by 2 months, both in the presence/absence of dermal fibroblasts (data not shown).
Three-dimensional models represent the most accurate method of modelling skin complex biological processes in vitro. Also, genetically modified mouse models have a lot to offer in the study of skin disease research. However, the difficulties to establish long-term cultures of murine epidermal keratinocytes have hindered the development of murine 3D cultures.
We have established a non-transformed murine keratinocyte cell line that grows on conventional cell culture plastic dishes without the need of feeder cells or coating matrix. Also, cell growth is done in easy-to-use commercially available defined cell culture media. We have termed this murine keratinocyte cell line COCA and we show its capacity to grow in 3D in vitro models and to reconstitute epidermis in cell grafting assays in vivo.
In agreement with previous studies [14, 18], COCA keratinocytes show a tendency to tetraploidy when subcultured. SKY analyses revealed that while at passage 8 cells were still diploid, at passage 77 they were almost tetraploid. However, COCA cells seem more stable than previously reported cells that were nearly tetraploid after 8 to 10 passages . This could be partly due to improved cell culture conditions or to the fact that COCA cells were established from adult mice keratinocytes instead from newborn pups. SKY analyses also revealed a clonal translocation between chromosomes 2 and 4 that occurred early in the culture.
All the same, these alterations in chromosome number are not linked to defects in differentiation. When induced to differentiate by raising the calcium concentration in the culture media, COCA cells expressed the early differentiation-specific keratin K10 and the terminal differentiation marker loricrin, with timing and pattern conserved in early throughout late passages. In the skin, keratinocyte differentiation is accompanied by a permanent arrest in proliferation. Similarly, COCA cells arrest their proliferation when induced to differentiate by calcium and they hardly re-enter in cell cycle when stimulated again with low calcium growth medium . This is indicative of a postmitotic terminally differentiated cell, characteristic of differentiated keratinocytes in vivo.
Next, we showed that COCA are also able to establish 3D models where keratinocytes are induced to differentiate by creating an air/liquid interface. Even late passage COCA keratinocytes (>75) are able to form an organised epidermis-like structure where proliferating cells are situated in the basal layer and K10, loricrin and filaggrin expressing differentiated cells locate at suprabasal layers. There is an expansion in the expression of the basal keratinocyte K5 to suprabasal layers, and expression of K6, this could be indicative of increased proliferation. Also, some alterations are present in the normal sequence of differentiation marker expression. Of note, these alterations affecting the expression of differentiation markers K10, loricrin and filaggrin, were not observed in in vivo experiments, pointing out to a possible experimental limitation of the in vitro model. However, work done in our laboratory with keratinocytes from murine models bearing different genetic alterations show that these 3D in vitro models are useful to study some of the characteristics and behaviour of these cells (not shown).
In vivo assays using immunodeficient mice showed that COCA cells are non-tumorigenic. This was also supported by cell grafting assays where late passage COCA keratinocytes were capable of growing a well-preserved epidermal-like structure with no evident signs of tumoral alterations.
We have generated an epidermal murine keratinocyte cell line, termed COCA. We show that COCA keratinocytes can establish reproducible 3D models applicable to the study of skin biology. The method we have followed to obtain and culture this cell line can be used to successfully develop keratinocyte cell lines from mice with genetic modifications of interest in the field of skin disease. Also, COCA could be a good control when studying the biological implications of these alterations.
Grant support: Ministerio de Ciencia e Innovación (MICINN) grants SAF2008-0121, PS-010000-2008-7, Comunidad Autónoma de Madrid Oncocycle Program grant S2006/BIO-0232, and Ministerio de Sanidad y Consumo grant ISCIII-RETIC RD06/0020. CELLnTEC culture media were delivered by Genycell, Madrid. We acknowledge Dr. J.C. Cigudosa and M.C. Martín from Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncológicas (CNIO), for carrying out the cytogenetic analysis (SKY) and report. We thank Dr. F. Larcher (CIEMAT) for his valuable scientific advice.
- Green H, Kehinde O, Thomas J: Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proceedings of the National Academy of Sciences of the United States of America 1979, 76(11):5665–5668. 10.1073/pnas.76.11.5665PubMedPubMed CentralView Article
- O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H: Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981, 1(8211):75–78.View Article
- Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H: Permanent coverage of large burn wounds with autologous cultured human epithelium. The New England journal of medicine 1984, 311(7):448–451. 10.1056/NEJM198408163110706PubMedView Article
- Leigh IM, Purkis PE, Navsaria HA, Phillips TJ: Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. The British journal of dermatology 1987, 117(5):591–597. 10.1111/j.1365-2133.1987.tb07491.xPubMedView Article
- Phillips TJ, Kehinde O, Green H, Gilchrest BA: Treatment of skin ulcers with cultured epidermal allografts. Journal of the American Academy of Dermatology 1989, 21(2 Pt 1):191–199.PubMedView Article
- Mils V, Basset-Seguin N, Moles JP, Tesniere A, Leigh I, Guilhou JJ: Comparative analysis of normal and psoriatic skin both in vivo and in vitro. Differentiation; research in biological diversity 1994, 58(1):77–86.PubMedView Article
- Barker CL, McHale MT, Gillies AK, Waller J, Pearce DM, Osborne J, Hutchinson PE, Smith GM, Pringle JH: The development and characterization of an in vitro model of psoriasis. The Journal of investigative dermatology 2004, 123(5):892–901. 10.1111/j.0022-202X.2004.23435.xPubMedView Article
- Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, Schalkwijk J: Development and validation of human psoriatic skin equivalents. The American journal of pathology 2008, 173(3):815–823. 10.2353/ajpath.2008.080173PubMedPubMed CentralView Article
- Vailly J, Gagnoux-Palacios L, Dell'Ambra E, Romero C, Pinola M, Zambruno G, De Luca M, Ortonne JP, Meneguzzi G: Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene therapy 1998, 5(10):1322–1332. 10.1038/sj.gt.3300730PubMedView Article
- Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, Maruggi G, Ferrari G, Provasi E, Bonini C, et al.: Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nature medicine 2006, 12(12):1397–1402.PubMedView Article
- Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975, 6(3):331–343. 10.1016/S0092-8674(75)80001-8PubMedView Article
- Hager B, Bickenbach JR, Fleckman P: Long-term culture of murine epidermal keratinocytes. The Journal of investigative dermatology 1999, 112(6):971–976. 10.1046/j.1523-1747.1999.00605.xPubMedView Article
- Hakkinen L, Koivisto L, Larjava H: An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci 2001, 23(4):189–196. 10.1023/A:1016385109922PubMedView Article
- Yano S, Okochi H: Long-term culture of adult murine epidermal keratinocytes. The British journal of dermatology 2005, 153(6):1101–1104. 10.1111/j.1365-2133.2005.06832.xPubMedView Article
- Caldelari R, Suter MM, Baumann D, De Bruin A, Muller E: Long-term culture of murine epidermal keratinocytes. The Journal of investigative dermatology 2000, 114(5):1064–1065. 10.1046/j.1523-1747.2000.00960-4.xPubMedView Article
- Reichelt J, Haase I: Establishment of spontaneously immortalized keratinocyte lines from wild-type and mutant mice. Methods in molecular biology (Clifton, NJ) 585: 59–69.
- MacNeil S: Progress and opportunities for tissue-engineered skin. Nature 2007, 445(7130):874–880. 10.1038/nature05664PubMedView Article
- Bruegel Sanchez VL, Zhou J, LaCivita D, Milstone LM: Long-term murine keratinocyte cultures become tetraploid, yet maintain the ability to stratify. The Journal of investigative dermatology 2004, 123(2):403–404. 10.1111/j.0022-202X.2004.23218.xPubMedView Article
- Lorz C, Segrelles C, Garin M, Paramio JM: Isolation of adult mouse stem keratinocytes using magnetic cell sorting (MACS). Methods in molecular biology (Clifton, NJ) 2010, 585: 1–11. 10.1007/978-1-60761-380-0_1View Article
- Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH: Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980, 19(1):245–254. 10.1016/0092-8674(80)90406-7PubMedView Article
- Stanley JR, Yuspa SH: Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol 1983, 96(6):1809–1814. 10.1083/jcb.96.6.1809PubMedView Article
- Yuspa SH, Kilkenny AE, Steinert PM, Roop DR: Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 1989, 109(3):1207–1217. 10.1083/jcb.109.3.1207PubMedView Article
- Strachan LR, Ghadially R: Limiting dilution analysis of murine epidermal stem cells using an in vivo regeneration assay. Methods in molecular biology (Clifton, NJ) 2010, 585: 421–432. 10.1007/978-1-60761-380-0_29View Article
- Segrelles C, Moral M, Lorz C, Santos M, Lu J, Cascallana JL, Lara MF, Carbajal S, Martinez-Cruz AB, Garcia-Escudero R, et al.: Constitutively Active Akt Induces Ectodermal Defects and Impaired Bone Morphogenetic Protein Signaling. Mol Biol Cell 2008, 19(1):137–149.PubMedPubMed CentralView Article
- Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, Garcia-Escudero R, Martinez-Cruz AB, Martinez-Palacio J, Hernandez P, et al.: Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006, 25(8):1174–1185. 10.1038/sj.onc.1209155PubMedView Article
- Schmidt M, Good RA: Letter: Cancer xenografts in nude mice. Lancet 1976, 1(7949):39.PubMedView Article
- Sharkey FE, Fogh J: Considerations in the use of nude mice for cancer research. Cancer metastasis reviews 1984, 3(4):341–360. 10.1007/BF00051459PubMedView Article
- Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A, Paramio JM, Vooijs M: Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 2004, 131(11):2737–2748. 10.1242/dev.01148PubMedView Article
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-5945/11/9/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.